• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Experimental drug believed to have helped critically ill emergency room doctor recover from COVID-19 (Autoimmune/cytokine release syndrome drug)

Emily

Editor, Senior Moderator
https://komonews.com/news/coronaviru...-from-covid-19
Experimental drug helped critically ill emergency room doctor recover from COVID-19
by Kara Kostanich, KOMO News Reporter
Thursday, April 9th 2020

...
He was first treated at Evergreen Hospital and was then moved to Swedish where doctors tried an experimental drug called Actemra.

Swedish Hospital said they believe the experimental drug helped Padgett recover.

“It would be fair to say we have treated patients with this medicine who have gotten quite ill and gotten better,” said Dr. Krish Patel who is the director of the lymphoma program at Swedish Cancer Institute First Hill.

The drug is showing promise in COVID patients whose bodies have a vigorous immune response to the virus.

“We do know when the immune system is overactive is can make the patient very sick in a short amount of time,” said Patel.
 
Back
Top